StockVS

Churchill Capital Corp X (CCCX) Stock Analysis

Financial Services

Churchill Capital Corp X

$13.66

+$0.45 (+3.37%)

Last Updated: February 13, 2026

Price History

Analysis

Company Overview

Churchill Capital Corp X operates within the financial services sector, specifically functioning as a shell company that focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more other entities. This industry classification indicates a corporate vehicle designed primarily to facilitate a reverse merger or business combination rather than traditional operational revenue generation. The company's current scale is represented by a market capitalization of $711.00M, while its annual revenue and employee count are not publicly disclosed in the available financial data. These valuation metrics suggest the company holds a significant market position relative to typical shell entities, reflecting the premium investors place on the potential for a future business combination transaction rather than current operational output.

Financial Health

The company reports a net income of $-31,429,724 over the trailing twelve months, while revenue and EBITDA figures are not available for disclosure. The substantial gap between the reported net income loss and the unavailable revenue data reveals a cost structure where operating expenses or transaction-related costs have significantly outweighed any recorded revenue streams. Free cash flow is not available, which limits the ability to assess the company's immediate financial flexibility or its capacity to fund ongoing operations without external capital injection. All three margin metrics, including gross margin, operating margin, and profit margin, are recorded at 0.0%, indicating that the company has not generated sufficient profitability to cover its costs or that no revenue has been recognized to calculate these percentages. The company holds $1.14M in cash, whereas debt and the debt-to-equity ratio are not available, creating a picture of a balance sheet that relies heavily on its cash reserves rather than leverage. The current ratio stands at 0.04, a figure that indicates severe short-term liquidity constraints, as the company's current assets are less than 5% of its current liabilities. Return on Equity and Return on Assets are both marked as N/A, which reveals that management has not yet demonstrated effectiveness in generating returns on the capital employed due to the lack of positive earnings and the specific nature of the shell company structure.

Valuation Assessment

The trailing P/E ratio and forward P/E ratio are both listed as N/A, which implies that there is no earnings trajectory to evaluate given the company's consistent net losses and lack of positive earnings history. The price-to-book ratio is reported at -18.71, a negative figure that indicates the market values the company significantly below its book value or that the book value itself is negative due to the accumulated losses and asset structure. Price-to-sales ratio and EV/EBITDA are both N/A, suggesting that traditional multiple-based valuation methods are inapplicable for this asset due to the absence of sales data and earnings before interest, taxes, depreciation, and amortization. The stock's recent price action has seen a 52-week high of $27.50 and a 52-week low of $10.03, with the current market price fluctuating within this range based on investor sentiment regarding potential merger targets. The beta value is N/A, which means there is insufficient historical volatility data relative to the broader market to calculate a standard risk metric for this specific security.

Growth & Income

Revenue growth year-over-year and earnings growth year-over-year are both N/A, indicating that the company does not possess a historical growth rate to compare against its current performance as it exists as a pre-merger entity. Since the company does not pay dividends, the dividend yield and payout ratio are N/A and 0.0% respectively, which confirms that the company reinvests its limited resources or potential proceeds into the pursuit of a business combination rather than distributing income to shareholders. The absence of a dividend program aligns with the growth strategy of a shell company that prioritizes capital preservation for a future transaction over providing current cash returns to investors. Consequently, the overall growth and income profile is defined by a lack of historical financial expansion and an absence of income generation, with all value propositions dependent on the successful execution of a future merger or acquisition event.

Peer Comparison

Churchill Capital Corp X (CCCX) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Churchill Capital Corp X CCCX $711.00M N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5
Bain Capital GSS Investment Corp. BCSS $595.68M N/A

The Shell Companies industry average P/E ratio is 82.8x. Churchill Capital Corp X trades at a P/E of N/A.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Churchill Capital Corp X

As of February 13, 2026, Churchill Capital Corp X was acquired by ColdQuanta, Inc., in a reverse merger transaction. Churchill Capital Corp X focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2024 and is based in New York, New York.

Key Statistics

Market Cap
$711.00M
P/E Ratio
N/A
52-Week High
$27.50
52-Week Low
$10.03
Avg Volume
2.12M

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NASDAQ
Country
United States